What amount sold does CREMMJOY, INC. report in Form D filings?

The latest linked filings report $2.7M sold across 2 identified offering(s). 1 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was CREMMJOY, INC.'s most recent SEC filing?

CREMMJOY, INC.'s most recent Form D filing was on 2026-11-03.

How many investors does CREMMJOY, INC. have?

The most recent Form D filing lists 31 investor(s).

What type of securities does CREMMJOY, INC. offer?

CREMMJOY, INC.'s SEC Form D filings indicate equity offerings.

CREMMJOY, INC.

CIK: 0002035571·Manufacturing·BATON ROUGE, LA·Corporation

Reported Sold

$2,702,333

Total Filings

Identified Offerings

Last Filed

Nov 3, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately. 1 unlinked amendment excluded.

About

Company in Manufacturing industry

SEC EDGAR

Offering filing timeline

Nov 3, 2026Form D — New notice

Reported sold: $1,681,000 · Target: $3,000,000

Rule 506(b)·31 investors

Dec 4, 2025Form D/A — Amendment

Reported sold: $2,671,333 · Target: $2,800,000

No verified predecessor available.

Rule 506(b)·24 investors

Aug 30, 2024Form D — New notice

Reported sold: $1,021,333 · Target: $2,800,000

Rule 506(b)·24 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

33%

Latest reported sold across 2 identified offerings

$2,702,333

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

1 unlinked amendment excluded.

Key People

JASON HUGENROTH

Executive Officer, Director

Appears on 3 filings

DANIEL FIELDS

Executive Officer, Director

Appears on 3 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Nov 3, 2026	New	$3,000,000	$1,681,000	31
Dec 4, 2025	Amendment	$2,800,000	$2,671,333	24
Aug 30, 2024	New	$2,800,000	$1,021,333	24

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

RxFunction, Inc.

Manufacturing

Offering target: $4,290,592

Filed Oct 14, 2026